EA
ACOR

Emerald Acquisition’s Acorda Therapeutics ACOR Stock Holding History

Emerald Acquisition’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$708K Buy
283
+40
+16% +$119K ﹤0.01% 2293
2016
Q2 		$743K Buy
+243
New +$790K ﹤0.01% 2316

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Emerald Acquisition's ACOR Position: Q3 2016 in Review

Emerald Acquisition increased its Acorda Therapeutics (ACOR) stake by 16% in Q3 2016, buying an estimated $119K and bringing the position to 283 shares worth $708K. The position accounts for ﹤0.01% of the portfolio, ranked #2293.

Emerald Acquisition first reported a position in ACOR in Q2 2016 and has held it in 2 quarters since. The position peaked at $743K in Q2 2016. 167 funds tracked by Wall St. Rank hold ACOR as of Q3 2016.

  • Emerald Acquisition held 283 shares of Acorda Therapeutics worth $708K as of Q3 2016.
  • Emerald Acquisition bought 40 Acorda Therapeutics shares in Q3 2016, an estimated $119K.
  • Acorda Therapeutics made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2293 holding.
  • Emerald Acquisition first reported a position in Acorda Therapeutics in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Acorda Therapeutics position peaked at $743K in Q2 2016.
  • 167 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.